EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Selenoprotein N and SEPN1-Related Myopathies: Mechanisms, Models, and Therapeutic Perspectives

Martina Lanza, Ester Zito iD, Giorgia Dinoi iD, Antonio Vittorio Buono, Annamaria De Luca iD, Paola Imbrici iD, Antonella Liantonio iD, Elena Conte iD

Biomolecules · 2026

DOI: 10.3390/biom16010125 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Martina Lanza und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, University of Salento, 73100 Lecce, Italy. Hauptthemen laut MEDLINE: Selenoproteins, Muscular Diseases, Muscle Proteins. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP), Ministry of University and Research, National Recovery and Resilience Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Selenoprotein N (SelN or SELENON) is a selenium-containing protein of the endoplasmic/sarcoplasmic reticulum (ER/SR), encoded by the SEPN1 gene. In skeletal muscle, SelN is particularly important for regulating SR calcium homeostasis. It acts as a calcium sensor, modulating the activity of the sarcoplasmic reticulum calcium pump (SERCA) through a redox-dependent mechanism. Loss-of-function mutations in the SEPN1 gene give rise to a spectrum of skeletal muscle disorders collectively referred to as SEPN1-related myopathies (SEPN1-RM). Histopathologically, SEPN1-RM is characterized by the presence of minicores, which are localized regions within muscle fibers exhibiting mitochondrial depletion (i.e., cores) and sarcomeric disarray. As no effective therapy is currently available for SEPN1-RM, understanding SelN biology through loss-of-function models remains essential for elucidating disease mechanisms and identifying potential therapeutic targets. This review examines the current knowledge on SelN function and the pathological mechanisms underlying SEPN1 loss-of-function, with a particular focus on the connection between calcium handling, oxidative/ER stress, and muscle dysfunction. It also highlights emerging strategies aimed at restoring SelN activity or mitigating downstream defects, outlining potential therapeutic avenues for SEPN1-RM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SelenoproteinsMuscular DiseasesMuscle ProteinsHumansAnimalsMuscle, SkeletalCalciumEndoplasmic Reticulum Stress

Stichwörter der Autor:innen

ER stressSelenoprotein Nmyopathyskeletal muscle

Substanzen

SelenoproteinsSELENON protein, humanMuscle ProteinsCalcium

Autor:innen und Institutionen

  • Department of Experimental Medicine, University of Salento, 73100 Lecce, Italy.
  • Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
  • Department of Biomolecular Sciences, University of Urbino Carlo Bo, 61029 Urbino, Italy.
  • Department of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.

ORCID-Profile: Ester Zito, Giorgia Dinoi, Annamaria De Luca, Paola Imbrici, Antonella Liantonio, Elena Conte

Förderung

  • Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP)
  • Ministry of University and Research
  • National Recovery and Resilience Plan

Zitieren

APA

Lanza, M., Zito, E., Dinoi, G., Buono, A. V., De Luca, A., Imbrici, P., Liantonio, A., & Conte, E. (2026). Selenoprotein N and SEPN1-Related Myopathies: Mechanisms, Models, and Therapeutic Perspectives. Biomolecules. https://doi.org/10.3390/biom16010125

Vancouver

Lanza M, Zito E, Dinoi G, Buono AV, De Luca A, Imbrici P, et al. Selenoprotein N and SEPN1-Related Myopathies: Mechanisms, Models, and Therapeutic Perspectives. Biomolecules. 2026. doi:10.3390/biom16010125

BibTeX
@article{Lanza2026,
  author = {Lanza, Martina and Zito, Ester and Dinoi, Giorgia and Buono, Antonio Vittorio and De Luca, Annamaria and Imbrici, Paola and Liantonio, Antonella and Conte, Elena},
  title = {Selenoprotein N and SEPN1-Related Myopathies: Mechanisms, Models, and Therapeutic Perspectives},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16010125}
}
Kostenlos starten →